NCT06159959View on ClinicalTrials.gov

Carbetocin in the Prevention of Primary Postpartum Haemorrhage

CompletedOBSERVATIONAL
Enrollment

244

Participants

Timeline

Start Date

January 1, 2023

Primary Completion Date

October 1, 2023

Study Completion Date

October 30, 2023

Conditions
Post Partum Hemorrhage
Interventions
DRUG

Carbetocin

To assess the effectiveness of single IV bolus dose of carbetocin in the prevention of primary PPH in obese versus non obese women undergoing elective cesarean section.

Trial Locations (1)

Unknown

Kasr- Alainy Hospitals, Cairo

All Listed Sponsors
lead

Ministry of Health and Population, Egypt

OTHER_GOV